Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$79.47 - $91.38 $377,959 - $434,603
4,756 Added 47.38%
14,795 $1.3 Million
Q1 2023

May 10, 2023

SELL
$76.72 - $87.58 $1.73 Million - $1.97 Million
-22,502 Reduced 69.15%
10,039 $809,000
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $99,719 - $114,851
-1,309 Reduced 3.87%
32,541 $2.53 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $1.34 Million - $1.58 Million
16,535 Added 95.5%
33,850 $2.73 Million
Q2 2022

Aug 12, 2022

BUY
$87.4 - $113.09 $1.51 Million - $1.96 Million
17,315 New
17,315 $1.55 Million
Q1 2022

May 13, 2022

SELL
$100.58 - $112.38 $607,100 - $678,325
-6,036 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $600,763 - $771,099
6,036 New
6,036 $624,000
Q3 2021

Nov 15, 2021

SELL
$122.75 - $135.17 $1.28 Million - $1.41 Million
-10,421 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$118.19 - $131.5 $1.23 Million - $1.37 Million
10,421 New
10,421 $1.29 Million
Q1 2021

May 12, 2021

SELL
$111.18 - $119.74 $13.1 Million - $14.1 Million
-117,643 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$100.57 - $117.14 $11.8 Million - $13.8 Million
117,643 New
117,643 $13.8 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.